Connect with us

Business

CV Sciences Inc. (OTCMKTS: CVSI) Launches Four Over The Counter +PlusCBD Pain Relief Topicals

Published

on

CV Sciences Inc. (OTCMKTS: CVSI) has launched four distinctive over-the-counter +PlusCBD Pain Relief topicals that have been formulated to target sources of minor aches and pains using active ingredients that include cooling menthols and warming camphor alongside premium hemp-derived CBD and other natural skin-softening emollients effects. 

CV science unveils +PlusCBD Pain Relief Sport Recovery Stick 

The +PlusCBD Pain Relief Sports Recovery Stick is designed for active and on-the-go athletes and fitness lovers. The topical analgesic and anti-inflammatory stick are designed to provide short relief from inflammation and pain while also assisting in the recovery process after physical activity. In addition, the 1 oz Sports Recovery Stick comes in a handy portable size for on-the-go applications.

The +PlusCBD Pain Relief Penetrating Cream is another topical analgesic cream developed to increase the icy-heat impacts of camphor and menthol, blended with hemp-derived CBD, to relieve occasional pain from tight muscles and aching joints.

Individuals suffering from transitory muscle pain, stiffness, or soreness as a result of strain, stress, overuse, or other minor injuries may benefit from the +PlusCBD Pain Relief Muscle Cream.

Finally, the +PlusCBD Pain Relief Arthritis Cream is designed for arthritis sufferers, who account for about 22% of all adults in the United States. The chemicals in the medication are designed to reduce arthritis-associated pain and discomfort in the joints.

CV Sciences products are available in 8,400 locations

CEO of CV Sciences Joseph Dowling said, “Finding new ways to improve our customers’ quality of life is at the heart of what we do at CV. Our latest range of Over-the-Counter Pain Relief topical products offer a non-invasive, holistic alternative to other OTC pain relievers, using the highest quality hemp-derived CBD, and camphor and menthol to alleviate common sources of pain. Our +PlusCBD Pain Relief product line is just another example of how science-backed innovations in CBD can transform the way we approach health and wellness.”

According to SPINS, the Company’s +PlusCBD products are offered in over 8,400 retail locations across the United States, and it is one of the top-selling hemp-derived CBD brands in the natural products industry.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.

FEATURED STORIES

Business2 days ago

Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) Expects Revenue Growth Of 17% To 23% In Q4 2021

Post Views: 204 Delta 9 Cannabis Inc. (OTCMKTS: DLTNF) has offered guidance on select Q4 and year-end financial results for...

Business2 days ago

CV Sciences Inc. (OTCMKTS: CVSI) Launches Four Over The Counter +PlusCBD Pain Relief Topicals

Post Views: 138 CV Sciences Inc. (OTCMKTS: CVSI) has launched four distinctive over-the-counter +PlusCBD Pain Relief topicals that have been...

Business2 days ago

AmericaCann Inc. (OTCMKTS: ACAN) Announce 225% Yoy Revenue Growth For 2020/2021 Calendar Year

Post Views: 128 AmericaCann Inc. (OTCMKTS: ACAN) has announced that its YoY revenue for the calendar year of 2020-2021 surpassed...

Business2 days ago

Australis Capital Inc. (OTCMKTS: AUSAF) Enters Asian Market Through Strategic Collaboration With Golden Triangle Health (GTH)

Post Views: 188 Australis Capital Inc. (OTCMKTS: AUSAF), which operates as AUDACIOUS, has announced a definitive deal with Golden Triangle...

INDUSTRIAL HEMP3 days ago

Halo Collective Inc. (OTCMKTS: HCANF) Signs $14 Million Unsecured Loan Agreement With Global Tech Opportunities 6

Post Views: 49 Halo Collective Inc. (OTCMKTS: HCANF) has announced the signing of a Loan Agreement with Global Tech Opportunities...

Business3 days ago

Mydecine Innovations Group (OTCMKTS: MYCOF) Engages JBN Partners and Attains AI Breakthrough in psychedelics Drug Development

Post Views: 45 Mydecine Innovations Group (OTCMKTS: MYCOF) has announced the engagement of JBN Partners LLC to boost public awareness...